Bayer Investor Relations

Team having a chat

Events /// Investor News /// Investment Case /// Resources

 

Bayer is committed to providing sustainable solutions that address humanity’s most fundamental needs for essential healthcare and nutritious food. The Bayer Investor Relations Team is dedicated to creating transparency, fostering dialogue, and delivering value to our stakeholders. 

Hands holding a smartphone with a double exposure background of indoor blinds and outdoor glass structures.
May 12, 2026
Investor Video Call
Q1 2026 Results
read more
Financial Reports
Quarterly Reports
Annual Reports
Investor Resources
Our Mission & Strategy
Investor Downloads
Newsletter Subscription
E-mail Investor Relations 
Digital Report Q1 2026
Man looking at tablet
Open the Report
Show more Events and Presentations
Investor News
Share Price / Index
June 17, 2026
Not intended for UK Media
Bayer completes acquisition of Perfuse Therapeutics
READ MORE
June 15, 2026
Bayer’s low-dose MRI contrast agent approved in U.S.
READ MORE
June 10, 2026
European Medicines Agency confirms Bayer’s FXIa inhibitor marketing authorization application for assessment in secondary prevention of ischemic stroke
READ MORE
NEWS OVERVIEW
Show More Investor News
An aerial view of a curved, modern office building with an adjacent circularly designed garden, featuring a large Bayer Cross embedded in the ground at its center.
Discover More
Scientist holding a plant
Mission & Strategy

Busting Bureaucracy, Igniting Innovation

LEARN MORE
Digital innovation, woman eyes in the background with digital structure in front of her
Breakthrough Innovation

Driving Positive Change for People and the Planet

LEARN MORE
Children holding hands
Sustainability Commitment

Making the Right Decisions, Responsibly

LEARN MORE
Hands holding a smartphone with a double exposure background of indoor blinds and outdoor glass structures.
Corporate Governance

Transparent and Responsible Style of Management

LEARN MORE